Officinal European Leonurus cardiaca, East Asian L. japonicus, and South African Leonotis leonurus are traditionally used for cardiovascular, gynecological, and neurological disorders. Nevertheless, a phytochemical assessment as a basis for their quality control and comparison amongst them has not yet been reported up to now. Here, a novel RP-HPLC method is presented for quantifying twelve phenolics, lavandulifolioside, verbascoside, hyperoside, ferulic acid, isoquercitrin, rutoside, apigenin-7-O-D-glucoside, and quercitrin, as well as chlorogenic, caffeic, rosmarinic, and cichoric acids, in 18 herbal and fruit samples of the three species, as well as in a L. cardiaca refined extract. Only ferulic acid was found in every sample, whereas rosmarinic acid and apigenin-7-O-Dglucoside were not detected in any sample. Chlorogenic, caffeic, and cichoric acids and rutoside were detected in all three species. Lavandulifolioside and verbascoside, the dominant phenolics of L. cardiac, were not present in any sample of L. japonicus. Lavandulifolioside was found in this first ever HPLC analysis on phenolics of L. leonurus. Hyperoside was not found in L. cardiaca, but in both L. japonicus and L. leonurus, whereas isoquercitrin was detected in L. cardiaca and L. leonurus, but not in L. japonicus. This approach facilitates identification and quality control via HPLC/HPTLC fingerprints.
Tea preparations from aerial parts of the European medicinal plant Leonurus cardiaca L. (Ph.Eur.) have traditionally been used for centuries as a remedy against tachyarrhythmia, heart failure, and other cardiac disorders [1, 2] . It is traditionally used both in the form of tea preparations and as alcoholic tinctures [1] . Strong cardiovascular and antiarrhythmic effects of L. cardiaca and a newly developed refined extract have been confirmed experimentally in a study with ex situ Langendorff rabbit hearts and cultivated cardiomyocytes in a voltage clamp setup in our lab [3] . Leonurus japonicus Houtt. [4, 5] (syn.: L. sibiricus L., L. heterophyllus Sweet [4, 5] , L. artemisia (Lour.) S.Y. Hu) is the source plant of the TCM drugs yimucao (L. japonici herba) (Chin. Ph., DAB) and chongweizi (L. japonici fructus) (Chin. Ph.) [6] . It is used both on the continent and in Japan as an uterotonic [7, 8] , for improving blood circulation and heart conditions [7, 8] , as a sedative [7] , and against dermatological disorders [7] .
Regarding this background, a detailed quantitative analysis of the phenolic compound spectrum of both Leonurus species could contribute significantly to our understanding of their pharmacological activity. The same holds true for the closely related South African herb Leonotis leonurus (L.) R.Br., which is used by South African traditional healers with similar indications as L. cardiaca [9] . Its cardioactivity has been proven in a recent study in the Langendorff isolated rat heart model [10] .
Although the phenolic constituents of the Leonurus and Leonotis species have been reported to contribute significantly to their pharmacological activity [11] , these substances are neither used as analytical markers at present nor have they ever been systematically assessed. This is an especially pressing problem as due to their inclusion in Ph. Eur. and DAB, respectively, L. cardiacae herba and L. japonici herba are both readily available , often in powdered state in German pharmacies, where repeated mix-ups in individual prescriptions have been reported. Even outside of this context, the L. cardiacae herba drug is generally considered to require urgent analytical re-evaluation [12, 13] .
The newly developed RP-HPLC gradient elution method described below enabled the simultaneous quantitative determination of twelve potentially active constituents of two Leonurus and one Leonotis species (Table 1 ) either in their traditional form as tea preparations or TCM decoctions [1, 7, 9] . The analytes were identified by their relative retention times (t R ) compared with the internal standard herniarin (IS) and by comparison of the UV spectra of the respective peaks with those of the pure standards. Typical HPLC chromatograms of the three species investigated were found to be significantly different displaying clearly distinguishable individual profiles.
Lavandulifolioside (5) , verbascoside (6) , and isoquercitrin (8) , which were found to be the dominant constituents of L. cardiaca, could not be found in any of the examined L. japonicus samples, whereas hyperoside (7) , a dominant constituent of L. japonicas, was not detected in even a single sample of L. cardiaca. Interestingly, while containing lavandulifolioside (5) in considerable amounts, its sister phenylethanoid glycoside verbascoside (6) was apparently not present in L. leonurus. As far as the examined fruits are concerned, they contained only minor amounts of all examined phenolics with chlorogenic acid (1), caffeic acid (2), ferulic acid (3), and cichoric acid (4) most pronounced in the TCM fruit drug of L. japonicus, whilst caffeic acid (2), ferulic acid (3), isoquercitrin (8), rutoside (9), and quercitrin (12) were detected in the not pharmaceutically used fruits of L. cardiaca.
Amongst the twelve quantified compounds, only ferulic acid (3) was found in every single sample, whereas rosmarinic acid (10) and apigenin-7-O-D-glucoside (11) could not be detected in any sample. All quantitative results from the HPLC observation were in good accordance with the results obtained from the additional qualitative HPTLC experiments. Leonoside A (13) and B (14) could not be detected in any samples at the current HPTLC detection limits. Based on previous taxonomically less clear protocols [14, 15] , the presented method offers, for the first time, the possibility to identify clearly the three examined plant drugs with a simple TLC test. The three identified taxonomic marker substances lavandulifolioside (5), verbascoside (6) , and hyperoside (7) could be easily identified by a simple fingerprint HPTLC, thus facilitating the clear identification of the three drugs, even from their extracts. The rising demand for imports of L. japonici herba by German TCM practitioners has already promoted the adoption of yimucao (L. japonici herba) to the current DAB [16] as one of the very first in a series of further additions of East Asian drugs. An international attempt to develop monographs for the pharmaceutical analysis of prominent TCM drugs yielded an HPLC method for L. japonici herba, which concentrated on the flavonol-glycosides hyperoside and rutin, as well as on the iridoid-glycoside ajugoside, the latter however without reference substance. All three were measured in the more unselective very short wave UV at 205 nm [15] , leading to the misidentification of hyperoside in the co-investigated L. cardiaca sample. With only two phenolics analyzed, this HPLC fingerprint approach thus seems hardly suitable for a clear differentiation between the two Leonurus species.
In this context, our findings should have implications concerning practical pharmacy: Since the recent addition of yimucao (L. japonici herba) to DAB, the two -especially in the dried statemorphologically very similar and hardly differentiable herbs of the same genus are present side by side in German pharmacies without a reliable chromatographic method for their differentiation. Here, the described HPLC method, based on our previous preliminary results [17] , facilitates separation and quantification of twelve distinct phenolics in the two drugs using a simple low cost method.
The presence of both of the phenylethanoids lavandulifolioside (5) and verbascoside (6) is a positive taxonomical marker for L. cardiacae herba and a negative marker for L. japonici herba. The reverse is true for the flavonol-glycoside hyperoside (7) , which was present in every sample of L. japonici herba, but was never found in any L. cardiaca sample. In the case of L. leonurus, hyperoside (7) and lavandulifolioside (5) were detected, but not verbascoside (6) . Thus, this validated HPLC method allows the identification and quantification of the main phenolics present in the two most extensively used Leonurus species.
As for comparison of our findings with previous literature data [11, 16, 18, 19, 20] , we can state that most of the previously reported constituents of the examined drugs could be retrieved alongside several substances which are reported here as ingredients of the respective species for the first time. In L. cardiaca, the known phenolics rutoside (9), isoquercitrin (8), quercitrin (12) , and lavandulifolioside (5) were detected, in addition to the newly identified chlorogenic acid (1), caffeic acid (2), ferulic acid (3), cichoric acid (4), and verbascoside (6) . Astonishingly, hyperoside (7) and apigenin-7-O-D-glucoside (11), which had been described as components of L. cardiaca extracts by Kartnig et al. [18] , could not be detected in any of the examined samples of this species. One has, however, to keep in mind that the report of Kartnig et al. [18] is very superficial and does not give any details on the identification of the described compounds beyond the statement that "the glycosides, their aglycones, and sugars were identified by standard spectroscopic, co-chromatographic, and hydrolytic technics [sic.]", without giving any further details. The claims by Kartnig et al. [18] have therefore to be taken with a grain of salt.
L. japonici herba was demonstrated to contain chlorogenic acid (1), caffeic acid (2), ferulic acid (3), and cichoric acid (4), for the first time. Rutoside (9) and hyperoside (7) , which has already been reported from this source by [16, 19] , were also identified. However, isoquercitrin, which was reported as a constituent of this plant in literature [19] , could not be rediscovered. The same is true for several other phenolics reported by Schmidt et al [21] for Leonurus sibiricus, a common synonym of L. japonicus.
However, as they have specifically examined L. sibiricus samples from Mongolia for use in traditional Mongolian medicine, it is highly probable that they have indeed examined samples of the rare authentic North Asian L. sibiricus in contrast to L. japonicus, which has been traded for decades under this false synonym. Consequently, differences in the phytochemical composition of the drug samples examined by Schmidt et al. [21] and those in the present project are to be expected. As the taxonomyof the genus Leonurus is currently very insecure, questionable identities of examined drug samples in previously published studies of plant samples referred to by the same botanical name might not always be actually the same species. In order to provide a basis for the further clarification of this problem, we are currently working on a state of the art scientific re-evaluation of the taxonomy of this genus.
The fruits of neither Leonurus species have ever been analyzed previously for their phenolic constituents. Thus, the substances identified in these parts (see above) are reported here for the first time. In L. leonurus, caffeic acid (2), ferulic acid (3), cichoric acid (4), lavandulifolioside (5), hyperoside (7) , isoquercitrin (8) , and rutoside (9) were all newly discovered, while its single previously (1), Rutoside (9) reported phenolic constituent, acteoside [20] , which is supposed to be identical to verbascoside (6), could not be detected. This difference may be explained by the examination of a sample from domestic cultivation in contrast to material from the tropics that was used in [20] . As far as the identification of possible active substances in L. japonicus is concerned, it is interesting to note that in recently published observations of patients by TCM therapists of the DECA (Gesellschaft für die Dokumentation von Erfahrungsmaterial der Chinesischen Arzneitherapie) the effect of dynamisation of the 'xue' according to Chin. Ph. appears clearly more intensive than the effects of Chinese reference samples [22] . Accordingly, the study at hand demonstrates that the content of the flavonoid glycosides hyperoside (7) and rutoside (9) are substantially higher in the herb from German cultivation (H and I) than in any of the imported samples from East Asia (A-G). In the case of hyperoside (7) the highest content in any imported material was found in sample F (0.017 %), while the lowest content in a domestic German drug was 0.038 % in sample H; sample I contained 0.091 % of hyperoside (7) . Concerning rutoside (9), the domestic samples demonstrated contents of 0.08 (I) and 0.12 % (H), with the highest amount found in the imports being just 0.039 % (G). These observations are not astonishing, as the overall flavonoid content, measured according to the Ph. Eur. monograph for L. cardiaca, of the different cultivars obtained from Asia was used as a marker for drug quality in the initial cultivation study [23] , thus leading to a selection of plants with high flavonoid content for commercial cultivation. Therefore, our findings hint at the potential contribution of these two substances to the overall pharmaceutical effect of L. japonicus in clinical TCM practice.
Taking into consideration that the refined extract of L. cardiaca (R) has been developed via bioassay guided fractionation [3] , it is to be expected that active constituents of the plant are enriched whereas inactive substances are diminished in this preparation. Under this premise, the present observations show that the only not noticeably enriched ingredients of the drug (M) from which the refined extract was prepared are lavandulifolioside (5) and verbascoside (6), exactly the same phenylethanoids that are perceived as the active constituents of this drug in recent pharmacological literature [11] .
Further, several of the small phenolics like chlorogenic acid (1), caffeic acid (2), ferulic acid (3), and cichoric acid (4) were accumulated in the cardioactive fraction during the preparation of the refined extract, featuring five (1), four (2), eight (3), and nine (4) fold increases in the refined extract, thus further hinting at the potential activity of these small phenolic molecules. Especially the concentration of ferulic acid (3), which has already been described as cardioactive [24] , was eightfold increased in the refined extract, making its contribution to the observed antiarrhythmic effect probable.
All in all, it can clearly be stated that the pharmacological activities of the examined traditionally used medicinal plants from East Asia, Europe, and South Africa cannot be traced to one active compound but have to be regarded as the orchestrated effect of the entire spectrum of their phenolic constituents.
Experimental
Plant material: The Ph. Eur. drug Leonuri cardiacae herba, the air dried aerial parts of L. cardiaca, and the Chin. Ph. drugs L. japonici herba and L. japonici fructus were purchased from the sources listed in (Table 1) with quality according to the requirements of either the Ph. Eur. or Chin. Ph. respectively. Leonotis leonurus was cultivated in the gardens of botany of Leipzig University. Fresh flowering aerial parts were collected for examination. A voucher specimen of these is deposited in the above mentioned herbarium under the registration number LZ 203520.
Extract preparation:
Pulverized drug material (6.00 g) was extracted with boiling water (120 mL) for 60 min under reflux. The resulting infusion was filtered under vacuum until the residue was dry and the liquid clear. It was subsequently evaporated to dryness and lyophilized. All extracts were powdered and stored in sealed glass flasks at -20°C.
HPLC:
Serial tests were conducted for standard solutions in the target absorption range (325-355 nm) resulting in the selection of 330 nm as the optimal detection wavelength yielding the best sensitivity, especially for minor compounds of the extracts. Under these conditions all examined bands were well or at least baseline separated. All samples were applied to a 250/4 Nucleodur 100-5 C18 ec column (5 µm) with a respective precolumn (Macherey-Nagel, Düren) by a Dionex Gina 50 autosampler. HPLC was carried out with a MeOH / H 2 O gradient (Table 3) . A Dionex UVD340U photodiode array detector was used for peak identification via 3Dspectra and quantification at 330 nm. Software: Chromeleon 6.70 (Dionex Corporation, Sunnyvale). Approximately 5 mg freeze-dried plant extract were resolubilized at a concentration of exactly 5 mg/mL. The filtered solution (780 µL) was mixed with 20 µL of herniarin solution (0.1 mg/mL) as internal standard (IS). Fifteen µL of these mixtures was injected onto the HPLC column for each measurement. As two phenylethanoids isolated from L. glaucescens [25] did not seem to be present in the extracts of L. cardiaca, L. japonicus, and L. leonurus according to preliminary HPTLC studies, they were excluded from further HPLC examinations.
Calibration mixtures were prepared, yielding definite concentrations of both the internal standard herniarin (IS) and all analyzed components in the same order of magnitude as in the examined samples, thus facilitating the simultaneous determination of all these 
L. japonici herba Beijing Beitaipingzhuang Dayaofang Beijing Shengshilong 0807183 Province of Hebei (PRC) 0.004 In a dilution series, the detection limits were determined as 5.0 µg / mlL in the case of rosmarinic acid (10) and apigenin-7-O-Dglucoside (11); 2.5 µg/mL for lavandulifolioside (5) , verbascoside (6), hyperoside (7) , and isoquercitrin (8); 1.0 µg/mL for cichoric acid (4), rutoside (9) , and quercitrin (12) ; and finally 0.5 µg/mL in the case of chlorogenic acid (1), caffeic acid (2), and ferulic acid (3), as well as for the internal standard herniarin (IS) under the applied HPLC conditions. The peak purity of all quantified substances in the crude extract was examined using the DAD detector. It could be concluded that the developed analytical method is suitable, i.e. precise, accurate, and specific, for its intended use. 
